Xinrong Ma Selected Research

Xinrong Ma Research Topics

Disease

21	Neoplasms (Cancer) 08/2021 - 06/2002
17	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2005
16	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2004
2	Ductal Carcinoma 01/2015 - 01/2014
1	Adenocarcinoma 08/2021
1	Warts (Wart) 08/2021
1	Stomach Neoplasms (Stomach Cancer) 08/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Hypersensitivity (Allergy) 01/2020
1	Triple Negative Breast Neoplasms 01/2017
1	Cicatrix (Scar) 09/2014
1	Hemangioma (Angioma) 09/2014
1	Dehydration (Water Stress) 11/2008

Drug/Important Bio-Agent (IBA)

8	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2017 - 03/2006
7	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 03/2006
4	Chemokine ReceptorsIBA 01/2019 - 08/2006
4	InterferonsIBA 01/2019 - 06/2002
4	ProstaglandinsIBA 01/2017 - 10/2006
3	Dinoprostone (PGE2)FDA Link 01/2017 - 02/2012
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2014 - 01/2004
3	AH 23848IBA 01/2014 - 03/2006
3	frondoside AIBA 01/2014 - 02/2012
3	Small Interfering RNA (siRNA)IBA 01/2014 - 09/2009
3	Prostaglandins EIBA 04/2012 - 03/2006
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
2	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2015
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2014 - 10/2005
2	LigandsIBA 03/2009 - 10/2005
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2002 - 06/2002
2	RetinoidsIBA 10/2002 - 10/2002
1	Docetaxel (Taxotere)FDA Link 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	Dual OxidasesIBA 08/2021
1	Cisplatin (Platino)FDA LinkGeneric 08/2021
1	TESIBA 01/2021
1	venetoclaxIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Cycloheximide (Cicloheximide)IBA 01/2020
1	CXC ChemokinesIBA 01/2019
1	15-hydroxyprostaglandin dehydrogenaseIBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 02/2016
1	Aldehyde DehydrogenaseIBA 01/2014
1	EP4 Subtype Prostaglandin E ReceptorsIBA 01/2014
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2012
1	CytokinesIBA 02/2012
1	Estrogen ReceptorsIBA 02/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012
1	6-isopropoxy-9-oxoxanthene-2-carboxylic acidIBA 10/2010
1	Messenger RNA (mRNA)IBA 10/2010
1	Interferon-gamma (Interferon, gamma)IBA 09/2009
1	Abscisic AcidIBA 11/2008
1	Chemotactic FactorsIBA 07/2007
1	Chemokine CXCL9IBA 07/2007
1	Hormones (Hormone)IBA 10/2006
1	N- (1- (3- (4- ethoxyphenyl)- 4- oxo- 3,4- dihydropyrido(2,3- d)pyrimidin- 2- yl)ethyl)- N- pyridin- 3- ylmethyl- 2- (4- trifluoromethoxyphenyl)acetamideIBA 08/2006
1	ChemokinesIBA 08/2006
1	4- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acidIBA 03/2006
1	Histocompatibility Antigens Class IIBA 10/2005
1	Celecoxib (Celebrex)FDA Link 10/2005
1	Therapeutic UsesIBA 10/2005
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2005
1	hydrogen sulfite (bisulfite)IBA 01/2004
1	EnzymesIBA 01/2004
1	Thioredoxin-Disulfide ReductaseIBA 10/2002
1	Interferon-betaIBA 10/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 10/2002
2	Radiotherapy 08/2021 - 09/2014
2	Transplantation 01/2014 - 01/2004
1	Local Anesthesia 09/2014
1	Oral Administration 01/2013
1	Immunotherapy 07/2007